This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Dec:92 Suppl 2:1-13.

doi: 10.1111/j.1464-410x.2003.04389.x.

The story of the European Randomized Study of Screening for Prostate Cancer

F H Schröder¹, L J Denis, M Roobol, V Nelen, A Auvinen, T Tammela, A Villers, X Rebillard, S Ciatto, M Zappa, A Berenguer, A Paez, J Hugosson, P Lodding, F Recker, M Kwiatkowski, W J Kirkels; ERSPC

Affiliations

PMID: 14983946
DOI: 10.1111/j.1464-410x.2003.04389.x

Review

The story of the European Randomized Study of Screening for Prostate Cancer

F H Schröder et al. BJU Int. 2003 Dec.

. 2003 Dec:92 Suppl 2:1-13.

doi: 10.1111/j.1464-410x.2003.04389.x.

Authors

F H Schröder¹, L J Denis, M Roobol, V Nelen, A Auvinen, T Tammela, A Villers, X Rebillard, S Ciatto, M Zappa, A Berenguer, A Paez, J Hugosson, P Lodding, F Recker, M Kwiatkowski, W J Kirkels; ERSPC

Affiliation

¹ Department of Urology, Erasmus Medical Centre, Rotterdam, the Netherlands. e.vandenberg@erasmusmc.nl

PMID: 14983946
DOI: 10.1111/j.1464-410x.2003.04389.x

No abstract available

PubMed Disclaimer

Similar articles

Biopsy diagnosis of prostatic cancer--current areas of concern.
Feneley MR, Parkinson MC. Feneley MR, et al. J Clin Pathol. 1997 Apr;50(4):265-6. doi: 10.1136/jcp.50.4.265. J Clin Pathol. 1997. PMID: 9215135 Free PMC article. No abstract available.
The Finnish trial of prostate cancer screening: where are we now?
Finne P, Stenman UH, Määttänen L, Mäkinen T, Tammela TL, Martikainen P, Ruutu M, Ala-Opas M, Aro J, Karhunen PJ, Lahtela J, Rissanen P, Juusela H, Hakama M, Auvinen A. Finne P, et al. BJU Int. 2003 Dec;92 Suppl 2:22-6. doi: 10.1111/j.1465-5101.2003.04397.x. BJU Int. 2003. PMID: 14983949 Clinical Trial. No abstract available.
A Pragmatic Approach to Prostate Cancer Screening.
Tosoian JJ, Penson DF, Chinnaiyan AM. Tosoian JJ, et al. JAMA. 2024 May 7;331(17):1448-1450. doi: 10.1001/jama.2024.4089. JAMA. 2024. PMID: 38581253 No abstract available.
PSA Screening for Prostate Cancer.
Quaas J. Quaas J. Am Fam Physician. 2015 May 1;91(9):Online. Am Fam Physician. 2015. PMID: 25955746 Review. No abstract available.
Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?
Gosselaar C, Roobol MJ, Schröder FH. Gosselaar C, et al. BJU Int. 2005 Feb;95(2):231-7. doi: 10.1111/j.1464-410X.2005.05324.x. BJU Int. 2005. PMID: 15667646 Review.

See all similar articles

Cited by

Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges.
Earnshaw SR, Brogan AP, McDade CL. Earnshaw SR, et al. Pharmacoeconomics. 2013 Apr;31(4):289-304. doi: 10.1007/s40273-013-0037-6. Pharmacoeconomics. 2013. PMID: 23519744 Review.
Complications of initial prostate biopsy in a European randomized screening trial.
van den Heuvel S, Loeb S, Zhu X, Verhagen PC, Schröder FH, Bangma CH, Roobol MJ. van den Heuvel S, et al. Am J Clin Exp Urol. 2013 Dec 25;1(1):66-71. eCollection 2013. Am J Clin Exp Urol. 2013. PMID: 25374901 Free PMC article.
Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice.
Lojanapiwat B, Anutrakulchai W, Chongruksut W, Udomphot C. Lojanapiwat B, et al. Prostate Int. 2014 Sep;2(3):133-9. doi: 10.12954/PI.14054. Epub 2014 Jul 30. Prostate Int. 2014. PMID: 25325025 Free PMC article.
The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, Roobol MJ. Vedder MM, et al. Eur Urol. 2014 Dec;66(6):1109-15. doi: 10.1016/j.eururo.2014.08.011. Epub 2014 Aug 26. Eur Urol. 2014. PMID: 25168616 Free PMC article.
Active surveillance for prostate cancer: a legal perspective.
Venderbos LD, Roobol MJ, de Hoogh AN. Venderbos LD, et al. Am J Clin Exp Urol. 2014 Dec 25;2(4):323-31. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25606578 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information